The 4R Oncology® Model facilitates enhanced patient engagement and timely care provision by streamlining delivery of complex interdependent care. Implementation of the 4R Oncology® model in breast and lung cancer clinics has improved patients’ involvement in organizing their care, enabled the development of high-functioning multidisciplinary care teams, and helped to optimize the timing and coordination of sequence of care. In this episode, CANCER BUZZ speaks with Raymond Liu, MD, director of research of Hematology-Oncology in Kaiser Permanente Northern California, director of cancer survivorship in Kaiser Permanente San Francisco, and assistant clinical professor at UCSF, who shares how successful implementation of the 4R Oncology® model empowers patients and clinicians and coheres care teams.
“When people could see that plan, and they could bring that home with them, and they saw that it was all guideline-based and mapped through in a very, very detailed way, they were empowered to answer their questions, especially for their loved ones, and to really reflect on what was said [in the doctor-patient consultation] at home.” –Raymond Liu, MD
“Care is so complex now; our innovations are really, really going fast but we have not been able to deliver the care in a way that’s understandable sometimes, and so by putting it in a single care plan, the patients really engage with it, and we found that the call volumes came down.” –Raymond Liu, MD
Raymond Liu, MD
Director of Research of Hematology-Oncology
Kaiser Permanente Northern California
Oakland, CA
Director of Cancer Survivorship
Kaiser Permanente San Franciso
San Francisco, CA
Assistant Clinical Professor
University of California San Francisco
San Francisco, CA
This episode was developed in connection with the ACCC program Care Action Plans for People with Cancer. ACCC, in partnership with the Center for Business Models in Healthcare, is making 4R Care Sequences® available at no cost to ACCC members. 4R Oncology® is the intellectual property of CBM-HC (Executive Frameworks, Ltd.), but is not a commercial product or service. 4R Care Sequence® templates were developed based on studies sponsored by Genentech, Inc.
Resources:
4R Oncology®
JCO Article Fostering High-Functioning Team
JCO Impact of 4R Oncology® Model
Biomarker Testing for NTRK Gene Fusions
Cancer Care Team Mental Health: Normalizing Helpers Seeking Help
Key Highlights from an ACCC Survey on Remote Patient Monitoring
Alleviating the Psycho-social Burden of MPNs
Myelofibrosis: Advances in Treatment and Therapy
ACCC’s 2023 Advocacy Agenda and Priorities
Symptoms Scoring and Risk Stratification for Myelofibrosis
Utilizing Subcutaneous and IV Treatment for Improved Outcomes with Multiple Myeloma Patients
A Better Patient Experience in the Management of Incidental Lung Nodules
In the Know: New Treatment Guidelines for Myeloproliferative Neoplasms
Mitigating the Financial Burden of Cancer Diagnostics
Getting the Green Light for Precision Medicine Stewards
The Impact of Integrated Care on Myeloproliferative Neoplasms (MPNs)
Treatment Options for Patients with Multiple Myeloma Who Are Ineligible for Transplant
Best Practices in Caring for Patients with CLL in a Post-COVID Era
Addressing Regional Challenges to Equitable Care for Patients with CLL
Robots, Biologics, and Advocates: Lessons from the Pharmacy
Precision Medicine: Stories from the CRISPR Revolution
The Urgency of MPN Treatment – Why Timing Matters
The Role of Population Health Navigators
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain